Zobrazeno 1 - 10
of 81
pro vyhledávání: '"M P, Rudolf"'
Publikováno v:
Zeitschrift der Savigny-Stiftung für Rechtsgeschichte / Germanistische Abteilung; August 1915, Vol. 36 Issue: 1 p642-650, 9p
Autor:
Lamberty, Sonja Maria
Publikováno v:
Info DaF: Informationen Deutsch als Fremdsprache; June 2002, Vol. 29 Issue: 2-3 p155-156, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anna Klara Siess
Publikováno v:
Národní knihovna České republiky.
Publikováno v:
Chemistry & Biology; 1997, Vol. 4 Issue: 2 p160-160, 1p
Autor:
Bernhard Ryffel, O. Rutschi, L. Fauconnier, M. P. Rudolf, Thomas Secher, Agata Szade, S. C. Fas
Publikováno v:
Journal of Antimicrobial Chemotherapy. 66:1100-1109
To investigate the in vivo efficacy in a murine pulmonary infection model of panobacumab (KBPA101), a human IgM monoclonal antibody directed against the O-polysaccharide moiety of Pseudomonas aeruginosa serotype O11, and to describe the anti-inflamma
Publikováno v:
The Journal of Immunology. 157:5646-5652
Anti-IgE mAbs have always been used to trigger mediator release from basophils or mast cells. Now nonanaphylactogenic anti-human IgE Abs are in clinical evaluation as a therapeutic agent against atopic disease. We have found a mAb that is nonanaphyla
Publikováno v:
Methods in molecular medicine. 61
In the last decade, many antigens expressed by tumors and recognized by the immune system have been identified. Melanoma was among the first tumors found to express such tumor-associated antigens, and, therefore, melanoma is currently one of the best
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
Human Papillomaviruses (HPVs) are sexually transmitted pathogens, which are implicated in the etiology of cervical cancer. The early proteins E6 and E7 of HPV have transforming capacity and interfere with the cell cycle control of infected host cells
Publikováno v:
Current opinion in molecular therapeutics. 1(1)
Papillomavirus virus-like particles (VLPs) are empty, non-replicative, non-infectious particles that retain conformationally correct epitopes for the generation of antibody responses to the viral capsid proteins. Chimeric human papillomavirus (HPV) v